Multi-phase emulsions based on amphiphilic block copolymers
Abstract
An composition comprises (a) a continuous aqueous phase; (b) an oily phase; and (c) an amphiphilic emulsifying system comprising a block copolymer having the formula (A)p-(B)q-(C)r, in which (B)q is a hydrophilic block and (C)r is a hydrophobic block; wherein p, q and r are integers with the proviso that: if p is 0, then A is other than hydroxyl or reactive functional groups and the block copolymer is a diblock copolymer; B and C are each individual repeating) units; if p is >1, then the block copolymer is a triblock copolymer, in which (A)p is a hydrophobic block; the hydrophobic blocks (A)p and (C)r are each homopolymers or heteropolymers; the repeating units A and C are the same or different; and wherein the ratio q/(p+r) is sufficient high so that the hydrophilic-lipophilic balance value of the block copolymer is >10.
Claims
exact text as granted — not AI-modified1 . A composition comprising:
(d) a continuous aqueous phase comprising H, O, (e) an oily phase comprising oil; and (f) an amphiphilic emulsifying system stabilizing the interface between the oily phase and the continuous aqueous phase, comprising a block copolymer having the formula
(A)p-(B)q-(C)r
wherein:
p, q and r are integers with the proviso that:
if p is 0, then A is other than hydroxyl or reactive functional groups and the block copolymer is a diblock copolymer, in which (B)q is a hydrophilic block and (C)r is a hydrophobic block, B and C are each individual repeating units; if p is >1, then the block copolymer is a triblock copolymer, in which (B)q is a hydrophilic block and (A)p and (C)r are each hydrophobic blocks; the hydrophobic blocks (A)p and (C)r are each homopolymers or heteropolymers; A, B and C are each individual repeating units; the repeating units A and C are the same or different;
and wherein the ratio q/(p+r) is sufficient high so that the hydrophilic-lipophilic balance (HLB) of the block copolymer is >10.
2 . The composition of claim 1 , wherein p is 0 and A is methoxy.
3 . The composition of claim 1 , wherein the continuous aqueous phase comprises an antigen and/or a bioactive substance.
4 . The composition of claim 1 , wherein the oily phase entraps or encapsulates an antigen and/or a bioactive agent.
5 . The composition of claim i, wherein the oily phase further comprises an emulsion comprising:
(c) an internal aqueous phase comprising H 2 O, being dispersed in the oily phase; and (d) a lipophilic emulsifying system stabilizing the interface between the inner aqueous phase and the oily phase to form a water-in-oil (W/O) emulsion; wherein the composition is in the form of a W/O/W emulsion.
6 . The composition of claim 5 , wherein the lipophilic emulsifying system comprises at least one physiologically acceptable emulsifier selected from the group consisting of mannide monooleat and sorbitan esters.
7 . The composition of claim 5 , further comprising an antigen and/or a bioactive agent dissolved in the internal aqueous phase and/or in the continuous aqueous phase.
8 . The composition of claim 1 , wherein the block copolymer is bioresorbable.
9 . The composition of claim 1 , wherein the hydrophilic block (B)q is a liner polymer.
10 . The composition of claim 1 , wherein the repeating unit B is selected from the group consisting of ethylene oxide, vinylpyroolidone, and acrylamide.
11 . The composition of claim 1 , wherein the hydrophobic blocks (A)p and (C)r are each polyester polymers.
12 . The composition of claim 1 , wherein the hydrophobic blocks (A)p and (C)r are each aliphatic polyesters.
13 . The composition of claim 12 , wherein the aliphatic polyesters are polymers of dicarboxylic acids and a diols.
14 . The composition of claim 12 , wherein the repeating units A and C are each selected from the group consisting of hydroxyacids, lactones, and combinations thereof.
15 . The composition of claim 14 , wherein the hydroxyacids are selected from the group consisting of lactic acid, 6-hydroxycaproic acid, glycolic acid, malic acid monoesters, and combinations thereof.
16 . The composition of claim 14 , wherein the lactones are selected from the group consisting of ε-caprolactone, lactide, glycolide, para-dioxanones, and combinations thereof.
17 . The composition of claim 1 , wherein the hydrophobic blocks (A)p and (C)/r are each comprises a polymer selected from the group consisting of:
(i) a hydroxyacid-containing polymer: poly(lactide), poly(lactic acid), poly(lactide-co-glycolide), poly(glycolide), poly(lactic acid-co-glycolic acid), poly(malic acid), poly(malic acid ester), or poly(glycolic acid); (ii) a lactone-containing polymer: poly(lactide-co-ε-caprolactone), poly(ε-caprolactone), or poly(glycolide-co-ε-caprolactone); and (iii) a hydroxycaproic acid-containing polymer: poly(lactic acid-co-6-hydroxycaproic acid), or poly(glycolic acid-co-6-hydroxycaproic acid).
18 . The composition of claim 1 , wherein the block copolymer is selected from the group consisting of poly(ethylene glycol)-block-poly(lactide-co-ε-caprolactone), poly(ethylene glycol)-block-polylactide, and poly(ethylene glycol)-block-poly(ε-caprolactone).
19 . A block copolymer comprising the formula
(A)p-(B)q-(C)r wherein:
p, q and r are integers with the proviso that:
if p is 0, then A is other than hydroxyl or reactive functional groups and the block copolymer is a diblock copolymer, in which (B)q is a hydrophilic block and (C)r is a hydrophobic block; B and C are each individual repeating units;
if p is >1, then the block copolymer is a triblock copolymer, in which (B)q is a hydrophilic block and (A)p and (C)r are each hydrophobic blocks; the hydrophobic blocks (A)p and (C)r are each homopolymers or heteropolymers; A, B and C are each individual repeating units; the repeating units A and C are the same or different;
and wherein the ratio q/(p+r) is sufficient high so that the hydrophilic-lipophilic balance (1-1.03) of the block copolymer is >10.
20 . The block copolymer of claim 19 , wherein the hydrophilic block (B)q constitutes at least 50% by weight of the block copolymer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.